Can You Imagine How China Isotope & Radiation's (HKG:1763) Shareholders Feel About The 40% Share Price Increase?HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 28 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Can You Imagine How China Isotope & Radiation's (HKG:1763) Shareholders Feel About The 40% Share Price Increase?Simply Wall StSimply Wall St.January 10, 2020ReblogShareTweetShareView photosThe simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by picking above-average stocks. For example, the China Isotope & Radiation Corporation (HKG:1763) share price is up 40% in the last year, clearly besting the market return of around 5.3% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend. Check out our latest analysis for China Isotope & Radiation While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.During the last year, China Isotope & Radiation actually saw its earnings per share drop 9.8%.So we don't think that investors are paying too much attention to EPS. Indeed, when EPS is declining but the share price is up, it often means the market is considering other factors.We think that the revenue growth of 21% could have some investors interested. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best.You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).SEHK:1763 Income Statement, January 10th 2020MoreIt's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. If you are thinking of buying or selling China Isotope & Radiation stock, you should check out this free report showing analyst profit forecasts.A Different PerspectiveChina Isotope & Radiation shareholders should be happy with the total gain of 41% over the last twelve months. And the share price momentum remains respectable, with a gain of 8.6% in the last three months. Demand for the stock from multiple parties is pushing the price higher; it could be that word is getting out about its virtues as a business. Is China Isotope & Radiation cheap compared to other companies? These 3 valuation measures might help you decide.For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on HK exchanges.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextbioMérieux S.A. Full-Year Results: Here's What Analysts Are Forecasting For Next YearSimply Wall St.Are Dividend Investors Getting More Than They Bargained For With Euroz Limited's (ASX:EZL) Dividend?Simply Wall St.Why BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.Should You Buy Antevenio, S.A. (EPA:ALANT) For Its Dividend?Simply Wall St.Here's What Absolent Group AB (publ)'s (STO:ABSO) P/E Is Telling UsSimply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhy We’re Not Keen On YHI International Limited’s (SGX:BPF) 3.8% Return On CapitalSimply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video